YXYuexian Xing

Yuexian Xing

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuexian Xing has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Fang Jia

    Department of Cardiovascular Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, China

    1 shared publication
  • Jingru Wang

    Department of Endocrinology, The Third Affiliated Hospital of Soochow University, Changzhou, China

    1 shared publication
  • Kaiming Luo

    Department of Endocrinology, The Third Affiliated Hospital of Soochow University, Changzhou, China

    1 shared publication
  • Long Wang

    The Third Affiliated Hospital of Soochow University

    1 shared publication
  • Man Li

    Department of Endocrinology, The Third Affiliated Hospital of Soochow University, Changzhou, China

    1 shared publication
  • Shoukui Xiang

    Department of Endocrinology, the Third Affiliated Hospital of Soochow University, Changzhou, China.

    1 shared publication

Latest Publications

  • Exploring the potential application of roxadustat in chronic kidney disease-related osteoporosis based on the regulatory role of HIF-1α in bone metabolism.

    by Jingru Wang, Shoukui Xiang, Yuexian Xing

    Oxygen is an essential element in the process of cellular oxidation, and hypoxia, a state of insufficient oxygen, can profoundly influence cellular adaptive responses through gene transcription, thereby impacting cell metabolism, angiogenesis, and inflammation. Hypoxia-inducible factor (HIF), particularly its alpha subunit (HIF-1α), is a critical transcription factor that orchestrates cellular adaptation to hypoxic environments and plays a multifaceted role in various cellular activities. In recent years, HIF-1α has been widely implicated in stimulating hematopoietic function and the good effect of roxadustat in treating renal anemia. However, the specific role of HIF-1α in bone metabolism remains unclear. More and more studies have shown that HIF-1α can not only directly affect osteoblasts, osteoclasts, osteocytes, and bone matrix during bone remodeling, but also locally and remotely regulate macrophages and various cytokines involved in bone remodeling. In addition, HIF-1α can indirectly regulate bone metabolism by promoting angiogenesis and regulating cell metabolism. This review comprehensively elucidates the intricate mechanisms by which HIF-1α influences bone metabolism. The aim is to provide a robust theoretical foundation for exploring the potential therapeutic application of roxadustat to improve bone metabolism in patients with Chronic Kidney Disease-related Osteoporosis (CKD-RO). It is important to note that, while this review highlights promising findings, the current evidence is primarily derived from preclinical animal studies and necessitates rigorous clinical validation.

  • Open Access

    RFX6 heterozygous frame-shift variation causes maturity- onset diabetes mellitus of the young (MODY) with refractory hyperlipidemia: a case report

    by Man Li, Long Wang, Yuexian Xing, Xiaolin Huang, Fang Jia, Wendong Xu, Kaiming Luo

    Case Report RFX6 heterozygous frame-shift variation causes maturity- onset diabetes mellitus of the young (MODY) with refractory hyperlipidemia: a case report Man Li, Long Wang, Yuexian Xing, Xiaolin Huang, Fang Jia, Wendong Xu, Kaiming Luo